LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1664

Search options

  1. Article ; Online: Reactive oxygen species in status epilepticus.

    Walker, Matthew C

    Epilepsia open

    2023  Volume 8 Suppl 1, Page(s) S66–S72

    Abstract: It has long been recognized that status epilepticus can cause considerable neuronal damage, and this has become one of its defining features. The mechanisms underlying this damage are less clear. Excessive activation of NMDA receptors results in large ... ...

    Abstract It has long been recognized that status epilepticus can cause considerable neuronal damage, and this has become one of its defining features. The mechanisms underlying this damage are less clear. Excessive activation of NMDA receptors results in large rises in internal calcium, which eventually lead to neuronal death. Between NMDA receptor activation and neuronal death are a number of intermediary steps, key among which is the generation of free radicals and reactive oxygen and nitrogen species. Although it has long been thought that mitochondria are the primary source for reactive oxygen species, more recent evidence has pointed to a prominent role of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, an enzyme localized in cell membranes. There is burgeoning in vivo and in vitro evidence that therapies that target the production or removal of reactive oxygen species are not only effective neuroprotectants following status epilepticus, but also potently antiepileptogenic. Moreover, combining therapies targeted at inhibiting NADPH oxidase and at increasing endogenous antioxidants seems to offer the greatest benefits.
    MeSH term(s) Humans ; Reactive Oxygen Species/metabolism ; Status Epilepticus/drug therapy ; Antioxidants/metabolism ; Antioxidants/pharmacology ; NADPH Oxidases/metabolism ; Mitochondria/metabolism ; Receptors, N-Methyl-D-Aspartate/metabolism
    Chemical Substances Reactive Oxygen Species ; Antioxidants ; NADPH Oxidases (EC 1.6.3.-) ; Receptors, N-Methyl-D-Aspartate
    Language English
    Publishing date 2023-01-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2470-9239
    ISSN (online) 2470-9239
    DOI 10.1002/epi4.12691
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical advances in the understanding, diagnosis, and treatment of epilepsy.

    Walker, Matthew C

    Current opinion in neurology

    2020  Volume 33, Issue 2, Page(s) 161–162

    Language English
    Publishing date 2020-02-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 1182686-1
    ISSN 1473-6551 ; 1350-7540
    ISSN (online) 1473-6551
    ISSN 1350-7540
    DOI 10.1097/WCO.0000000000000804
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Status epilepticus: what's new for the intensivist.

    Benghanem, Sarah / Robieux, Estelle Pruvost / Neligan, Aidan / Walker, Matthew C

    Current opinion in critical care

    2024  Volume 30, Issue 2, Page(s) 131–141

    Abstract: Purpose of review: Status epilepticus (SE) is a common neurologic emergency affecting about 36.1/100 000 person-years that frequently requires intensive care unit (ICU) admission. There have been advances in our understanding of epidemiology, ... ...

    Abstract Purpose of review: Status epilepticus (SE) is a common neurologic emergency affecting about 36.1/100 000 person-years that frequently requires intensive care unit (ICU) admission. There have been advances in our understanding of epidemiology, pathophysiology, and EEG monitoring of SE, and there have been large-scale treatment trials, discussed in this review.
    Recent findings: Recent changes in the definitions of SE have helped guide management protocols and we have much better predictors of outcome. Observational studies have confirmed the efficacy of benzodiazepines and large treatment trials indicate that all routinely used second line treatments (i.e., levetiracetam, valproate and fosphenytoin) are equally effective. Better understanding of the pathophysiology has indicated that nonanti-seizure medications aimed at underlying pathological processes should perhaps be considered in the treatment of SE; already immunosuppressant treatments are being more widely used in particular for new onset refractory status epilepticus (NORSE) and Febrile infection-related epilepsy syndrome (FIRES) that sometimes revealed autoimmune or paraneoplastic encephalitis. Growing evidence for ICU EEG monitoring and major advances in automated analysis of the EEG could help intensivist to assess the control of electrographic seizures.
    Summary: Research into the morbi-mortality of SE has highlighted the potential devastating effects of this condition, emphasizing the need for rapid and aggressive treatment, with particular attention to cardiorespiratory and neurological complications. Although we now have a good evidence-base for the initial status epilepticus management, the best treatments for the later stages are still unclear and clinical trials of potentially disease-modifying therapies are long overdue.
    MeSH term(s) Humans ; Status Epilepticus/diagnosis ; Status Epilepticus/drug therapy ; Seizures/drug therapy ; Valproic Acid/therapeutic use ; Levetiracetam/therapeutic use ; Benzodiazepines/therapeutic use ; Encephalitis ; Anticonvulsants/therapeutic use
    Chemical Substances Valproic Acid (614OI1Z5WI) ; Levetiracetam (44YRR34555) ; Benzodiazepines (12794-10-4) ; Anticonvulsants
    Language English
    Publishing date 2024-02-13
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 1235629-3
    ISSN 1531-7072 ; 1070-5295
    ISSN (online) 1531-7072
    ISSN 1070-5295
    DOI 10.1097/MCC.0000000000001137
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: How accurately do adult patients report their absence seizures?

    Pizarro, Joao / O'Sullivan, Suzanne / Walker, Matthew C

    Epilepsia open

    2023  Volume 8, Issue 2, Page(s) 641–644

    Abstract: We depend upon self-reporting to determine seizure frequency for epilepsy management decisions, but people often misreport their seizures. Here, we determined misreporting rates in adults with absence seizures, undergoing inpatient video-EEG telemetry ( ... ...

    Abstract We depend upon self-reporting to determine seizure frequency for epilepsy management decisions, but people often misreport their seizures. Here, we determined misreporting rates in adults with absence seizures, undergoing inpatient video-EEG telemetry (VET) or outpatient ambulatory electroencephalography (aEEG). Under-reporting rates were based on VET data, where behavior could be assessed, whilst over-reporting was assessed using both VET and aEEG. Forty-two patients (31 female and 11 males, median age 28.5 years) and 759 reported absence seizures were included in this study. Overall, only 24% of the 759 reported seizures had an associated EEG correlate, indicating a high over-reporting rate, which occurred in 57% of patients. Age, sex, time of epilepsy, VET versus aEEG, epilepsy syndrome, or medication were not significant predictors of over-reporting. In the VET group in which we could assess both over- and under-reporting (22 patients), only 2 patients correctly reported their seizures, and patients were predominantly over-reporters or under-reporters, not both. Only 26% of 423 absence seizures were reported. Use of zonisamide or valproate was associated with under-reporting, possibly through an impact on attention. These findings indicate that self-reported absence seizures are a poor measure to use for treatment decisions due to both over- and under-reporting.
    MeSH term(s) Male ; Humans ; Adult ; Female ; Seizures/diagnosis ; Seizures/drug therapy ; Epilepsy, Absence/diagnosis ; Epilepsy, Absence/drug therapy ; Zonisamide ; Valproic Acid/therapeutic use ; Inpatients
    Chemical Substances Zonisamide (459384H98V) ; Valproic Acid (614OI1Z5WI)
    Language English
    Publishing date 2023-03-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2470-9239
    ISSN (online) 2470-9239
    DOI 10.1002/epi4.12689
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Editorial.

    Walker, Matthew C

    Current opinion in neurology

    2017  Volume 30, Issue 2, Page(s) 165–166

    MeSH term(s) Anticonvulsants/therapeutic use ; Electroencephalography ; Epilepsy/classification ; Epilepsy/diagnosis ; Epilepsy/drug therapy ; Humans ; Seizures/physiopathology
    Chemical Substances Anticonvulsants
    Language English
    Publishing date 2017-02-15
    Publishing country England
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 1182686-1
    ISSN 1473-6551 ; 1350-7540
    ISSN (online) 1473-6551
    ISSN 1350-7540
    DOI 10.1097/WCO.0000000000000421
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The role of trained and untrained dogs in the detection and warning of seizures.

    Luff, Grace C / Belluomo, Ilaria / Lugarà, Eleonora / Walker, Matthew C

    Epilepsy & behavior : E&B

    2023  Volume 150, Page(s) 109563

    Abstract: Seizure unpredictability plays a major role in disability and decreased quality of life in people with epilepsy. Dogs have been used to assist people with disabilities and have shown promise in detecting seizures. There have been reports of trained ... ...

    Abstract Seizure unpredictability plays a major role in disability and decreased quality of life in people with epilepsy. Dogs have been used to assist people with disabilities and have shown promise in detecting seizures. There have been reports of trained seizure-alerting dogs (SADs) successfully detecting when a seizure is occurring or indicating imminent seizures, allowing patients to take preventative measures. Untrained pet dogs have also shown the ability to detect seizures and provide comfort and protection during and after seizures. Dogs' exceptional olfactory abilities and sensitivity to human cues could contribute to their seizure-detection capabilities. This has been supported by studies in which dogs have distinguished between epileptic seizure and non-seizure sweat samples, probably though the detection of volatile organic compounds (VOCs). However, the existing literature has limitations, with a lack of well-controlled, prospective studies and inconsistencies in reported timings of alerting behaviours. More research is needed to standardize reporting and validate the results. Advances in VOC profiling could aid in distinguishing seizure types and developing rapid and unbiased seizure detection methods. In conclusion, using dogs in epilepsy management shows considerable promise, but further research is needed to fully validate their effectiveness and potential as valuable companions for people with epilepsy.
    MeSH term(s) Animals ; Humans ; Dogs ; Prospective Studies ; Quality of Life ; Seizures/diagnosis ; Epilepsy/diagnosis ; Smell
    Language English
    Publishing date 2023-12-09
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2010587-3
    ISSN 1525-5069 ; 1525-5050
    ISSN (online) 1525-5069
    ISSN 1525-5050
    DOI 10.1016/j.yebeh.2023.109563
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Response: Drug resistance in epilepsy: A reappraisal of the definition is needed.

    Galanopoulou, Aristea S / Auvin, Stéphane / Moshé, Solomon L / Potschka, Heidrun / Rocha, Luisa / Walker, Matthew C

    Epilepsia

    2023  Volume 65, Issue 1, Page(s) 240–241

    MeSH term(s) Humans ; Epilepsy/diagnosis ; Epilepsy/drug therapy ; Drug Resistance
    Language English
    Publishing date 2023-11-15
    Publishing country United States
    Document type Letter
    ZDB-ID 216382-2
    ISSN 1528-1167 ; 0013-9580
    ISSN (online) 1528-1167
    ISSN 0013-9580
    DOI 10.1111/epi.17818
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The influence of temperature on performance, biological indices, composition, and nutrient retention of juvenile Chinook salmon (Oncorhynchus tshawytscha) reared in freshwater.

    Araújo, Bruno C / Miller, Matthew R / Walker, Seumas P / Symonds, Jane E

    Comparative biochemistry and physiology. Part A, Molecular & integrative physiology

    2023  Volume 280, Page(s) 111412

    Abstract: ... into twelve tanks of 8000 L each (155 to 157 fish per tank) at a temperature of 14 °C. The tanks were ... transitioned from 14 °C (hatchery temperature) to 8, 12, 16, and 20 °C over seven days. Three fish assessments ... observed in fish at 16 °C and 20 °C compared to the lower temperatures. Fish at higher temperatures had ...

    Abstract This study investigated the effects of different temperatures on the performance, composition, and nutrient retention of Chinook salmon reared in freshwater. Individuals (187.6 ± 27.1 g) were distributed into twelve tanks of 8000 L each (155 to 157 fish per tank) at a temperature of 14 °C. The tanks were transitioned from 14 °C (hatchery temperature) to 8, 12, 16, and 20 °C over seven days. Three fish assessments were performed, the first (initial) when the fish were distributed in the tanks, a second (interim) between days 9 and 16 at the start of the experiment, and a third (final) after 41 to 49 days at the target temperature. At the end of the trial, performance parameters, proximate composition, amino acid, and fatty acid composition, and nutrient retention were evaluated. Better growth performance was observed in fish at 16 °C and 20 °C compared to the lower temperatures. Fish at higher temperatures had higher levels of saturated fatty acids (SFA), while at lower temperatures fish had higher levels of n-3 and n-6 polyunsaturated fatty acids (PUFA), especially eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). A polynomial relationship between nutrient retention and temperature showed that fish from all treatments retained more lipids than proteins, with higher retention of MUFA compared to the other fatty acid classes. Additionally, DHA retention was approximately three times higher than EPA retention. The results showed that 16 to 20 °C was the optimum temperature range for Chinook salmon, and the performance differences were mainly modulated by lipid retention/catabolism.
    MeSH term(s) Animals ; Docosahexaenoic Acids/metabolism ; Eicosapentaenoic Acid/metabolism ; Fatty Acids ; Fresh Water ; Nutrients ; Salmon/metabolism ; Temperature
    Chemical Substances Docosahexaenoic Acids (25167-62-8) ; Eicosapentaenoic Acid (AAN7QOV9EA) ; Fatty Acids
    Language English
    Publishing date 2023-03-05
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial, Veterinary ; Research Support, Non-U.S. Gov't
    ZDB-ID 121246-1
    ISSN 1531-4332 ; 0300-9629 ; 1095-6433
    ISSN (online) 1531-4332
    ISSN 0300-9629 ; 1095-6433
    DOI 10.1016/j.cbpa.2023.111412
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The role of aberrant neural oscillations in the hippocampal-medial prefrontal cortex circuit in neurodevelopmental and neurological disorders.

    Shing, Nathanael / Walker, Matthew C / Chang, Pishan

    Neurobiology of learning and memory

    2022  Volume 195, Page(s) 107683

    Abstract: The hippocampus (HPC) and medial prefrontal cortex (mPFC) have well-established roles in cognition, emotion, and sensory processing. In recent years, interests have shifted towards developing a deeper understanding of the mechanisms underlying ... ...

    Abstract The hippocampus (HPC) and medial prefrontal cortex (mPFC) have well-established roles in cognition, emotion, and sensory processing. In recent years, interests have shifted towards developing a deeper understanding of the mechanisms underlying interactions between the HPC and mPFC in achieving these functions. Considerable research supports the idea that synchronized activity between the HPC and the mPFC is a general mechanism by which brain functions are regulated. In this review, we summarize current knowledge on the hippocampal-medial prefrontal cortex (HPC-mPFC) circuit in normal brain function with a focus on oscillations and highlight several neurodevelopmental and neurological disorders associated with aberrant HPC-mPFC circuitry. We further discuss oscillatory dynamics across the HPC-mPFC circuit as potentially useful biomarkers to assess interventions for neurodevelopmental and neurological disorders. Finally, advancements in brain stimulation, gene therapy and pharmacotherapy are explored as promising therapies for disorders with aberrant HPC-mPFC circuit dynamics.
    MeSH term(s) Humans ; Prefrontal Cortex/physiology ; Hippocampus/physiology ; Cognition ; Nervous System Diseases ; Neural Pathways/physiology
    Language English
    Publishing date 2022-09-26
    Publishing country United States
    Document type Review ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1223366-3
    ISSN 1095-9564 ; 1074-7427
    ISSN (online) 1095-9564
    ISSN 1074-7427
    DOI 10.1016/j.nlm.2022.107683
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Revisiting the concept of drug-resistant epilepsy: A TASK1 report of the ILAE/AES Joint Translational Task Force.

    Auvin, Stéphane / Galanopoulou, Aristea S / Moshé, Solomon L / Potschka, Heidrun / Rocha, Luisa / Walker, Matthew C

    Epilepsia

    2023  Volume 64, Issue 11, Page(s) 2891–2908

    Abstract: Despite progress in the development of anti-seizure medications (ASMs), one third of people with epilepsy have drug-resistant epilepsy (DRE). The working definition of DRE, proposed by the International League Against Epilepsy (ILAE) in 2010, helped ... ...

    Abstract Despite progress in the development of anti-seizure medications (ASMs), one third of people with epilepsy have drug-resistant epilepsy (DRE). The working definition of DRE, proposed by the International League Against Epilepsy (ILAE) in 2010, helped identify individuals who might benefit from presurgical evaluation early on. As the incidence of DRE remains high, the TASK1 workgroup on DRE of the ILAE/American Epilepsy Society (AES) Joint Translational Task Force discussed the heterogeneity and complexity of its presentation and mechanisms, the confounders in drawing mechanistic insights when testing treatment responses, and barriers in modeling DRE across the lifespan and translating across species. We propose that it is necessary to revisit the current definition of DRE, in order to transform the preclinical and clinical research of mechanisms and biomarkers, to identify novel, effective, precise, pharmacologic treatments, allowing for earlier recognition of drug resistance and individualized therapies.
    MeSH term(s) Humans ; United States ; Epilepsy/drug therapy ; Drug Resistant Epilepsy/drug therapy ; Drug Resistance ; Advisory Committees ; Incidence
    Language English
    Publishing date 2023-09-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 216382-2
    ISSN 1528-1167 ; 0013-9580
    ISSN (online) 1528-1167
    ISSN 0013-9580
    DOI 10.1111/epi.17751
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top